In a nutshell This study is examining the effectiveness of insulin inhaler Afrezza at mealtimes for patients with type 2 diabetes (T2D). The main outcome of the study will be the time patients’ blood glucose readings are in the ideal range. This study is recruiting in San Antonio, TX, US. The details T2D is a disease where a...
Read MoreClinical Trial Posts on Medivizor
Looking for patients with advanced non-Hodgkin lymphoma to test an experimental drug with three functions
In a nutshell This trial is examining the safety and effectiveness of experimental drug mRNA-2752 in patients with progressive non-Hodgkin lymphoma (NHL). The main outcome of the trial will be the number of side effects experienced by patients and response to treatment. This trial is recruiting in the United States and Israel. The details Patients...
Read MoreLooking for patients with advanced triple negative breast cancer to test an experimental drug with three functions
In a nutshell This trial is examining the safety and effectiveness of experimental drug mRNA-2752 in patients with advanced triple-negative breast cancer. The main outcome of the trial will be the number of side effects experienced by patients and response to treatment. This trial is recruiting in the United States and Israel. The details...
Read MoreLooking for participants with stroke to test a new treatment for mental symptoms
In a nutshell This trial is examining the effectiveness of a new behavioral treatment for patients with stroke. The main outcome to be measured will be participant satisfaction. This study is being conducted in New York, US. The details A stroke consists of a blockage of the blood flow to the brain by a blood clot (80% of the cases). This can...
Read MoreLooking for patients with diabetes mellitus to try an experimental treatment for fatty liver disease
In a nutshell This study is evaluating the effects of Aramchol on the outcomes of patients with diabetes mellitus who have fatty liver disease. The main outcome to be measured will be the number of patients who have minimal to no symptoms of disease after treatment. This study is recruiting in Arlington, Texas, US. The details About 40 – 50% of...
Read MoreLooking for patients with newly diagnosed multiple myeloma to test a combination therapy
In a nutshell This study is evaluating the safety and effectiveness of the D-KRd regimen (daratumumab, carfilzomib, lenalidomide, and dexamethasone) in patients with multiple myeloma. The main outcome to be measured will be the number of patients who respond to treatment. This study is recruiting in Chicago, Illinois. The details Multiple myeloma (MM)...
Read MoreLooking for patients with colorectal cancer to test a new therapy with tumor infiltrating lymphocytes
In a nutshell This phase 2 trial is examining the effectiveness of tumor-infiltrating lymphocytes (TIL) in the treatment of colorectal cancer. The main outcome to be measured is the tumor response to the treatment. This trial will be conducted in Texas, US. The details Cancer is one of the leading causes of death worldwide. Therapy such as...
Read MoreLooking for participants with stroke to test a new nerve stimulation treatment
In a nutshell This trial is examining a new treatment involving nerve stimulation for stroke survivors with arm/hand paralysis. The main outcome to be measured will be the change in wrist movement. This study is being conducted in New York, US. The details Stroke is the fifth leading cause of death in the US. A common side effect of stroke is weakness...
Read MoreSearching for patients with early breast cancer to trial a partial-radiation treatment
In a nutshell This trial aims to find out what dose of radiation therapy is effective in the shortest time period for women with newly diagnosed breast cancer, or ductal carcinoma in-situ (DCIS). The main outcome that will be measured is if patients experience any side effects. The study is taking place in New Jersey and New York, the United States. The...
Read MoreLooking for participants to test a new treatment for stroke recovery
In a nutshell This trial is examining the effectiveness of a new treatment called ischemic conditioning for the recovery of stroke survivors. The main outcome to be measured will be the change in walking speed. This trial will be conducted in Wisconsin, US. The details A stroke happens when the blood flow to the brain is cut off. The brain cells stop...
Read MoreLooking for patients with advanced prostate cancer to test a new treatment strategy
In a nutshell This phase 2 study will investigate cryosurgical freezing (CF) and intratumoral combination immunotherapy (ITI) in advanced prostate cancer (PC). The main outcome will be the reduction in prostate specific antigen (PSA). This trial is recruiting in California and Michigan, US. The details Metastatic prostate cancer (PC) is an...
Read MoreLooking for patients with advanced lung cancer to test a treatment combination
In a nutshell This phase 1/2 study will investigate the safety of a new drug, BMS-986156, combined with ipilimumab (Yervoy), nivolumab (Opdivo) and radiotherapy in advanced lung cancer (LC). The main outcomes will be the rate of dose-limiting side effects and response to treatment. This trial is recruiting in Texas, US. The details...
Read More
